ModelEdge
CollPlant Biotechnologies Ltd
CLGN
Filing type
20-F
Filing date
Mar 31, 2020
Updated
Apr 1, 2020 ยท 1:57 AM

Filing

20-FAnnual and Transition Report of Foreign Private Issuers

Exhibits

EX-2.1DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12EX-4.24FORM OF CONVERTIBLE LOAN AGREEMENT BETWEEN THE COMPANY AND AMY SAGYEX-4.25FORM OF CONVERTIBLE LOAN AGREEMENT BETWEEN THE COMPANY AND U.S. INVESTORSEX-4.26FORM OF PRICE PROTECTION AGREEMENT BETWEEN THE COMPANY AND AMY SAGYEX-4.27FORM OF PRICE PROTECTION AGREEMENT BETWEEN THE COMPANY AND U.S. INVESTORSEX-4.28FORM OF REGISTRATION RIGHTS AGREEMENTEX-4.29FORM OF WARRANT ISSUED BY THE COMPANY TO AMY SAGY AND U.S. INVESTORS PURSUANT TO THE CONVERTIBLE LOAN AGREEMENTEX-4.30FORM OF SECURITIES PURCHASE AGREEMENT DATED AS OF FEBRUARY 13, 2020 BY AND BETWEEN THE COMPANY AND THE PURCHASERS NAMED THEREINEX-12.1CERTIFICATIONEX-12.2CERTIFICATIONEX-13.1CERTIFICATIONEX-13.2CERTIFICATIONEX-15.1CONSENT OF KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicEX-101.INSXBRL INSTANCE FILE